Showing results (261-270 of 266) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 266 results.
Schizophrenia Bulletin|July 18, 2014
How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoiaDaniel Freeman, Graham Dunn, Robin M Murray, et al.
BMJ (Clinical Research Ed.)|April 12, 2012
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trialAnthony P Morrison, Paul French, Suzanne L K Stewart, et al.
The Lancet. Psychiatry|April 1, 2017
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trialIan M Anderson, Andrew Blamire, Tim Branton, et al.
BMC Psychiatry|October 23, 2015
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)Liam Trevithick, R Hamish McAllister-Williams, Andrew Blamire, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
The Lancet. Oncology|November 27, 2025
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trialsCecilie D Amdal, Ragnhild S Falk, Ahu Alanya, et al.
Pageof 27